Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2023 Sep 1.
Published in final edited form as: Environ Res. 2022 Jun 1;212(Pt E):113591. doi: 10.1016/j.envres.2022.113591

The association between oil spill cleanup-related total hydrocarbon exposure and diabetes

HV Jardel 1,*, LS Engel 1,2, KG Lawrence 2, PA Stewart 3, MR Stenzel 4, MD Curry 5, RK Kwok 2,6, DP Sandler 2
PMCID: PMC9267393  NIHMSID: NIHMS1815026  PMID: 35661735

Abstract

Background:

Although evidence suggests relationships between some crude oil components and glycemic dysregulation, no studies have examined oil spill-related chemical exposures in relation to type 2 diabetes mellitus (DM) risk. This study examined the relationship between total hydrocarbon (THC) exposure among workers involved in the 2010 Deepwater Horizon (DWH) oil spill and risk of DM up to 6 years afterward.

Methods:

Participants comprised 2660 oil-spill cleanup or response workers in the prospective GuLF Study who completed a clinical exam and had no self-reported DM diagnosis prior to the spill. Maximum THC exposure was estimated with a job-exposure matrix based on interview data and personal measurements taken during cleanup operations. We defined incident DM by self-reported physician diagnosis of DM, antidiabetic medication use, or a measured hemoglobin A1c value ≥ 6.5 %. We used log binomial regression to estimate risk ratios (RRs) for DM across ordinal categories of THC exposure. The fully adjusted model controlled for age, sex, race/ethnicity, education, employment status, and health insurance status. We also stratified on clinical body mass index categories.

Results:

We observed an exposure-response relationship between maximum daily ordinal THC exposure level and incident DM, especially among overweight participants. RRs among overweight participants were 0.99 (95% CI: 0.37, 2.69), 1.46 (95% CI: 0.54, 3.92), and 2.11 (95% CI: 0.78, 5.74) for exposure categories 0.30-0.99 ppm, 1.00-2.99 ppm, and ≥ 3.00 ppm, respectively (ptrend=0.03).

Conclusion:

We observed suggestively increasing DM risk with increasing THC exposure level among overweight participants, but not among normal weight or obese participants.

Keywords: diabetes, petroleum hydrocarbons, GuLF Study

Introduction/background

The 2010 Deepwater Horizon (DWH) oil spill is the largest recorded marine oil spill in the United States, releasing an estimated 205.8 million gallons of crude oil into the Gulf of Mexico over 87 days (1). Cleanup efforts included tens of thousands of workers (1). Workers experienced a variety of spill-related exposures as a function of the types, timing, and locations of their jobs/tasks, as weathering processes altered the geographic distribution and composition of the oil. Crude oil contains a range of volatile organic compounds that may contribute to an individual’s total hydrocarbon (THC) exposure. Among those volatile organic compounds, the best studied in relation to human glycemic dysregulation is benzene, which together with toluene, ethylbenzene, xylenes, and n-hexane comprise BTEX-H. The BTEX-H chemicals comprised approximately 18% by weight (approximately 30% by volume) of the volatile chemicals in the original crude oil (2), though the relative proportions to which workers were exposed varied based on the degree of weathering of the oil to which a worker was exposed.

Among the BTEX-H chemicals, benzene is the most well studied in relation to glycemic regulation. Non-occupational studies of elderly adults and children found a relationship between increased benzene exposure and increased insulin resistance (3,4). In mice, inhaled benzene induces similar indications of glycemic dysregulation, with hypothalamic inflammation and endoplasmic reticulum stress (5), as well as oxidative stress (6). Additionally, ingestion of benzene by rats has been associated with increased fasting blood glucose, blood insulin increases, and insulin resistance, as well as increased levels of oxidative species, decreased antioxidant capacity, and evidence of DNA damage in β-cells and liver cells. Little research has examined the other BTEX-H chemicals in relation to glycemic dysfunction, although one study found that inhaled toluene at repeated high doses was associated with persistent overall metabolic and glycemic dysfunction in rats fed a high fat diet (7).

Type 2 diabetes mellitus (DM) is characterized by a failure of glycemic homeostasis due to pancreatic β-cell dysfunction or somatic cell resistance to insulin. BTEX-H exposure may contribute to β-cell dysfunction via oxidative stress, which may overwhelm antioxidant mechanisms, given that exposure in human in vitro assays and rodent models leads to increased oxidative stress markers and oxidative DNA damage (8-18), which impairs β-cell function (19-23) and overall metabolic function (24-29).

This study examines the relationship between oil spill cleanup-related total hydrocarbon (THC) exposure and incident DM among individuals who worked on the 2010 Deepwater Horizon oil spill. To the best of our knowledge, this is the first study of oil spill chemical exposures and diabetes risk.

Methods

Study design and population

Participants in the present study were a subset of participants from the Gulf Long Term Follow-up Study, which is a prospective cohort of 32,608 individuals at least 21 years of age at enrollment who worked on the DWH spill cleanup and response or who completed oil spill cleanup safety training but did not participate in the cleanup (30).

Participants contributed data over multiple study phases, including; a) a structured telephone interview at enrollment (in English, Spanish, or Vietnamese) completed by all study participants (2011-2013) (n=32,608); b) a home visit involving an in-person interview and collection of biological samples, anthropometric measurements, and clinical measurements among cohort members residing in a state bordering the Gulf of Mexico (MS, AL, LA, FL, TX) (2011-2013) (n=11,193); c) a structured follow-up telephone interview targeting all English and Spanish speaking participants (2013-2016) (n=21,256); and d) a clinical exam involving an in-person interview and collection of anthropometric and hemoglobin A1c (HbA1c) measurements among a sample of cohort members restricted to those residing within 60 miles of study clinics in Mobile, AL or New Orleans, LA (2014-2016) (n=3,401).

This analysis focused on the 3,401 participants (62% of eligible participants) who completed the clinical exam. Of these, we excluded 528 who did not work on the spill to minimize potential bias from the healthy worker effect (31), 164 with a self-reported DM diagnosis prior to the spill (April 20th, 2010), 1 with probable type 1 DM (under 40 years old and prescribed insulin without other antidiabetic medication) (32), and 48 missing necessary covariate data, leaving 2,660 for these analyses (Table 1). Time from start of the spill to the clinical exam ranged across participants from 4 to 6 years. This study was approved by the institutional review board at the National Institute of Environmental Health Sciences (NIEHS) and all study participants provided informed consent.

Table 1:

Study population (n = 2709) characteristics at enrollment, except where indicated (overall and by diabetes status)

All participants
(n = 2709)
Diabetics
(n = 245)
Non diabetics
(n = 2464)
p-valueg
N
%
N
%
N
%

THC exposure level (ppm)a 0.77
  < 0.30 364 13.4 % 31 12.7 % 333 13.5 %
  0.30 – 1.99 850 31.4 % 73 29.8 % 777 31.5 %
  2.00 – 2.99 821 30.3 % 78 31.8 % 743 30.2 %
  ≥ 3.00 674 24.9 % 63 25.7 % 611 24.8 %
  Missing -- -- --
Age at clinical exam (y) <0.01
  < 35 596 22.0 % 19 7.8 % 577 23.4 %
  35 – 44 582 21.5 % 40 16.3 % 542 22.0 %
  45 – 54 754 27.8 % 78 31.8 % 676 27.4 %
  55 – 64 544 20.1 % 74 30.2 % 470 19.1 %
  ≥ 65 233 8.6 % 34 13.9 % 199 8.1 %
  Missing -- -- --
Sex 0.26
  Female 618 22.8 % 48 19.6 % 570 23.1 %
  Male 2091 77.2 % 197 80.4 % 1894 76.9 %
  Missing -- -- --
Race & Hispanic ethnicityb 0.44
  Non-Hispanic White 1353 50.1 % 115 46.9 % 1238 50.4 %
  Black 1122 41.5 % 168 45.7 % 1010 41.1%
  Other 226 8.4 % 34 7.4 % 208 8.5 %
  Missing 8 -- 8
Education 0.62
  No high school (HS) diploma 577 21.3 % 59 24.1 % 518 21.0 %
  HS diploma/Some college (no degree) 1488 55.0 % 133 54.3 % 1355 55.0 %
  College degree 643 23.7 % 53 21.6 % 590 24.0 %
  Missing 1 1 --
Employment statusc <0.01
  Working or student 1552 57.4 134 54.7 % 1418 57.7 %
  Unemployed 786 29.1 53 21.6 % 733 29.8 %
  Other 366 13.5 58 23.7 % 308 12.5 %
  Missing 5 0 5
Health insurance statusd <0.01
  Yes 1301 48.6 % 140 58.1 % 1161 47.7 %
  No 1374 51.4 % 101 41.9 % 1273 52.3 %
  Missing 34 4 30
BMI category (kg/m2)e <0.01
  Under/normal weight (< 25) 652 24.4 % 21 8.8 % 631 25.9 %
  Overweight (25 - 29) 861 32.2 % 48 20.0 % 813 33.4 %
  Obese (≥ 30) 1165 43.5 % 171 71.3 % 994 40.8 %
  Missing 31 5 26
Smoking statusf <0.01
  Current 1083 40.0 % 72 29.4 % 1011 41.1 %
  Former 717 26.4 % 98 40.0 % 619 25.1 %
  Never 906 33.5 % 75 30.6 % 831 33.7 %
  Missing 3 0 3

All data were from the Gulf Long Term Follow-up Study of individuals who worked for at least one day on the Deepwater Horizon oil spill cleanup and who completed a routine clinical exam as part of that study 4-6 years after the spill.

a

Maximum daily total hydrocarbon exposure experienced during work on the spill. Estimated via detailed self-report of spill-related tasks together with a job-exposure matrix based on extensive air monitoring during the spill cleanup (see Stewart et al. (2018))

b

Non-Hispanic White, Black (Hispanic and non-Hispanic), Other (Hispanic and non-Hispanic)

c

Working/student/on temporary sick leave; unemployed/keeping house; Other/retired/disabled

d

Health insurance status at the time of the home visit.

e

BMI at the time of the home visit. Calculated from the average height and average weight from three measurements each.

f

smoking status at the time of the clinical exam

g

P-values for Chi-squared tests for difference, which are crude and do not provide evidence of confounding or of a causal relationship

Total hydrocarbons ordinal exposure levels

Each worker’s exposure was defined as their maximum one-day THC exposure, as described below. The enrollment interviews administered to each participant included questions about activities performed, and locations and dates. GuLF Study industrial hygienists used this information together with THC measurements (analyzed as total petroleum hydrocarbons) from approximately 28,000 personal air samples collected from the general population of oil spill response and cleanup workers (for industrial hygiene purposes) to create a job-exposure matrix (33). Participants often performed multiple oil spill cleanup-related jobs/tasks in a single day and over their work period. Each person was assigned an exposure value for each job/task using the job-exposure matrix (33). The maximum daily value across all work days (33), which has been successfully used in other GuLF Study analyses and was the only quantitative chemical exposure measure available for these analyses, was used. Ordinal exposure levels were defined using a pseudo-log scale based on the empirical exposure distribution: <0.30 ppm, 0.30–0.99 ppm, 1.00–2.99 ppm, and ≥3.00 ppm (33). This analysis utilizes ordinal exposure categories, rather than continuous values, to reflect uncertainty in the exposure estimates derived from the job exposure matrix (33)

Diabetes assessment

Participants were treated as incident type 2 DM cases if they a) reported a post-spill physician diagnosis of DM at either the enrollment or first follow-up interviews, b) reported taking an antidiabetic medication at the time of the clinical exam, or c) had a HbA1c value at or above 6.5%, as measured by a DCA Vantage device (Siemens Medical Solutions USA, Inc.), during the clinical exam (34). Women reporting only gestational diabetes were not considered cases.

Participants who reported a physician diagnosis of DM were asked for either age or date of diagnosis; age at diagnosis was used to estimate date of diagnosis by calculating the middle month of their age-year of diagnosis. Date of diagnosis was used to identify incident cases of DM in relation to the start of the spill (April 20th, 2010), based on each participant’s earliest reported date of diagnosis.

Potential confounders

Potential confounders were selected based on a directed acyclic graph (DAG) (35). Data from the enrollment interviews included sex (female, male); race/ethnicity (Non-Hispanic White, Black/African American Hispanic and non-Hispanic, Other); highest educational attainment (less than high school, high school diploma/GED/some college, college degree); and employment status (working or student, looking for employment/keeping house, other). Smoking status was categorized as current, former, and never. Race/ethnicity data are values of racial self-classification - participants selected from a list including American Indian/Alaskan Native, Asian, Black/African American, Native Hawaiian/Pacific Islander, and White. Ethnicity was similarly ascertained and included Hispanic/Latino identity. Race and ethnicity were collapsed further because of small cell numbers. Information on health insurance status (insured, uninsured) was collected at the home visit. Age at the clinical exam was represented as restricted quadratic splines with knots at 35, 50, 67, and 77 years after assessing the functional form of age with the Akaike Information Criterion.

Body mass index (BMI) was not included as a confounder in the main analysis because weight and height data were collected after the exposure occurred and BMI could be a mediator of any THC-DM relationship, but it was considered in sub-analyses. BMI was categorized as underweight/normal weight, overweight, and obese (< 25 kg/m2, 25-25.9 kg/m2, ≥ 30 kg/m2, respectively) using measurements from the home visit. Height and weight were each measured three times and the average of each was used to calculate the home visit BMI (36).

Statistical analysis

We used log binomial regression to estimate risk ratios (RR) and corresponding 95% confidence intervals (95 % CIs) for DM through the date of the clinical exam by ordinal THC exposure level. In the main analysis, three adjustment models were used: 1) reduced model: age only; 2) basic model: age, sex, race/ethnicity, and education; 3) full model: age, sex, race/ethnicity, education, employment status, and health insurance status. For each model, we performed a trend test with the median value for each exposure category as a continuous measure; the corresponding p-value is the Wald statistic for that parameter. In all analyses the lowest exposure category, < 0.30 ppm, was the reference group. All tests for significance were assessed at an alpha level of 0.05. All analyses were conducted with SAS version 9.4 (SAS, Cary, NC).

The reduced, basic, and full models were applied to a) the entire analytic sample (n = 2660) and b) male workers only (n = 2051). The male-only analyses were conducted for two reasons. First, there may be sex-specific differences in biological response to THC components, as indicated by studies on humans (4) and mice (5), but there were too few women for separate analyses. Second, some women could have been prescribed metformin (a popular antidiabetic medication) for polycystic ovary syndrome rather than for diabetes (37). Although rare, polycystic ovary syndrome seems to have a higher prevalence in the southern US compared to other regions of the US (38).

Because BMI is a potential mediator, we separately examined associations adjusted for BMI by including it in the log binomial models, using the COPY method as needed to enable convergence (39,40). We also stratified by BMI, using the same three adjustment sets as in the main analysis. We additionally investigated multiplicative interaction between BMI and THC exposure levels in relation to diabetes risk, assessing effect measure modification with a likelihood ratio test (LRT) using fully adjusted log binomial models and the COPY method as needed.

Sensitivity analyses

We repeated the main analysis defining incident cases using each individual’s last date of spill-related employment rather than the start of the spill (April 20th, 2010) to assess the impact of including cases (n = 2644) diagnosed during the cleanup, which may be biased due to some cleanup workers’ changes in access to medical care during this period. We also performed sub-analyses a) including prediabetes (defined as 5.7% ≤ HbA1c < 6.5%) among the cases (34) and, separately, b) with cases restricted to individuals either with HbA1c ≥ 6.5% or reporting both DM diagnosis and use of antidiabetic medication. Because smoking is a risk factor for DM but was not strongly related to spill-related THC exposure (Spearman rho = −0.099), we conducted an additional sensitivity analysis in which we included it in the fully adjusted model.

Results

Compared to non-cases, cases were older, more likely to be male, more likely to self-identify as Black, less likely to have graduated from high school, more likely to be no longer working because of retirement or disability, more likely to have health insurance, and far more likely to be obese (Table 1). Among those who were eligible for the clinical exam, the proportion that participated in the clinical exam was similar between those reporting and not reporting a diabetes diagnosis at the follow-up interview (data not shown), suggesting little/no selection bias related to this factor.

All models utilizing the full sample showed an apparent exposure-response relationship of increasing DM incidence with increasing THC exposure level, although individual point estimates were not statistically significant. RRs from the full model were 1.07 (95% CI: 0.71, 1.62), 1.23 (95% CI: 0.82, 1.86), and 1.28 (95% CI: 0.83, 1.97), for exposure categories 0.30-0.99 ppm, 1.00-2.99 ppm, and ≥ 3.00 ppm, respectively, compared to exposures below 0.30 ppm (Table 2). Exposure-response relationships were somewhat stronger in models restricted to males. In these analyses, RRs for the full model were 1.27 (95% CI: 0.72, 2.24), 1.54 (95% CI: 0.89, 2.65), and 1.61 (95% CI: 0.92, 2.82), for exposure categories 0.30-0.99 ppm, 1.00-2.99 ppm, and ≥ 3.00 ppm, respectively (Table 2).

Table 2:

Associations between maximum total hydrocarbon (THC) exposure and risk of type 2 diabetes, with different adjustment sets

Age adjustmenta Basic adjustmentb Full adjustmentc
Full sample (n = 2660)
  Max THC (ppm)d n cases/n
total
RR 95% CI CLRe RR 95% CI CLR RR 95% CI CLR



   < 0.30 29/361 1 1 1
   0.30 - 0.99 72/840 1.11 (0.74, 1.68) 2.27 1.06 (0.70, 1.60) 2.29 1.07 (0.71, 1.62) 2.28
   1.00 - 2.99 77/802 1.20 (0.80, 1.80) 2.25 1.20 (0.79, 1.81) 2.29 1.23 (0.82, 1.86) 2.27
   ≥ 3.00 62/657 1.33 (0.88, 2.03) 2.31 1.25 (0.81, 1.92) 2.37 1.28 (0.83, 1.97) 2.37
Trend test p-value: 0.16 Trend test p-value: 0.26 Trend test p-value: 0.22
Males only (n = 2050)
  Max THC (ppm)
   < 0.30 14/209 1 1 1
   0.30 - 0.99 51/577 1.35 (0.77, 2.37) 3.08 1.27 (0.72, 2.24) 3.11 1.27 (0.72, 2.24) 3.11
   1.00 - 2.99 69/672 1.54 (0.89, 2.67) 3.00 1.52 (0.88, 2.63) 2.99 1.54 (0.89, 2.65) 2.98
   ≥ 3.00 58/592 1.67 (0.96, 2.92) 3.04 1.58 (0.90, 2.77) 3.08 1.61 (0.92, 2.82) 3.07
Trend test p-value: 0.10 Trend test p-value: 0.13 Trend test p-value: 0.10
a

Adjusted for age with restricted quadratic splines

b

Adjusted for age, sex, race/ethnicity, and education

c

Adjusted for age, sex, race/ethnicity, education, employment status, and health insurance status

d

Maximum total hydrocarbon exposure

e

Confidence limit ratio

In models stratified by BMI category, we observed an exposure-response relationship among overweight participants (ptrend= 0.03), although the point estimates were not statistically significant; the estimated basic adjustment RRs were 0.99 (95% CI: 0.37, 2.69), 1.46 (95% CI: 0.54, 3.92), and 2.11 (95% CI: 0.78, 5.74) for exposure categories 0.30-0.99 ppm, 1.00-2.99 ppm, and ≥ 3.00 ppm, respectively (Table 3). The point estimates within the obese category were all elevated, but with no apparent trend. Results from the underweight stratum were very unstable because of the small number of cases (n = 21) and are therefore not presented.

Table 3:

Associations between maximum total hydrocarbon (THC) exposure and risk of type 2 diabetes, stratified by body mass index category

Age adjustmenta Basic adjustmentb Full adjustmentc
Overweightd (n = 843)
  Max THC (ppm)f n cases/
n total
RR 95% CI CLRg RR 95% CI CLR RR 95% CI CLR



   < 0.30 5/114 1 1 -
   0.30 - 0.99 13/268 1.06 (0.39, 2.85) 7.24 0.99 (0.37, 2.69) 7.33 - - -
   1.00 - 2.99 15/258 1.34 (0.51, 3.54) 6.97 1.46 (0.54, 3.92) 7.20 - - -
   ≥ 3.00 15/203 2.14 (0.81, 5.61) 6.89 2.11 (0.78, 5.74) 7.39 - - -
Trend test p-value: 0.03 Trend test p-value: 0.03
Obesee (n = 1149)
  Max THC (ppm)
   < 0.30 18/160 1 1 1
   0.30 - 0.99 54/348 1.43 (0.87, 2.35) 1.43 1.37 (0.84, 2.24) 1.37 1.44 (0.88, 2.35) 1.44
   1.00 - 2.99 55/351 1.32 (0.81, 2.17) 1.32 1.22 (0.74, 2.01) 1.22 1.30 (0.79, 2.14) 1.30
   ≥ 3.00 42/290 1.33 (0.80, 2.23) 1.33 1.18 (0.70, 1.99) 1.18 1.19 (0.70, 2.01) 1.19
Trend test p-value: 0.76 Trend test p-value: 0.82 Trend test p-value: 0.73
Multiplicative interaction p-value 0.60
a

Adjusted for age with restricted quadratic splines

b

Adjusted for age, sex, race/ethnicity, and education

c

Adjusted for age, sex, race/ethnicity, education, employment status, and health insurance status. Model did not converge for overweight stratum due to insufficient cases.

d

BMI [25 – 29]

e

BMI ≥ 30

f

Maximum total hydrocarbon exposure

g

Confidence limit ratio

When incident cases were defined using the end, rather than the start, of each individual’s work on the spill, there was virtually no change in the pattern of increasing DM incidence with increasing THC exposure level (Supplementary Table S1). In analyses including both those with diabetes and prediabetes detected at clinical exam as cases, all RR estimates were attenuated and close to the null value of 1.00. Models using a stricter case definition based on either a) HbA1c ≥6.5% or b) both a DM diagnosis and use of antidiabetic medication also produced attenuated RR estimates. RR estimates were similar when models included BMI as a covariate, with RRs for the full model of 1.22 (95% CI: 0.80, 1.84), 1.25 (95% CI: 0.83, 1.89), and 1.27 (95% CI: 0.82, 1.96) for exposure categories 0.30-0.99 ppm, 1.00-2.99 ppm, and ≥ 3.00 ppm, respectively. In models including a multiplicative interaction between BMI and the exposure in the fully adjusted model, we observed no evidence of multiplicative interaction (p = 0.60). Estimates from the full model that included smoking status were nearly indistinguishable from those of the main analysis (Supplementary Table S2).

Discussion

This analysis showed an apparent exposure-response relationship of increasing DM incidence with increasing maximum THC exposure level, which appeared stronger among males, although the individual point estimates were not significant. Additionally, there was a significant exposure-response relationship among overweight participants, but not among obese participants.

Because this is the first study of DM risk in relation to oil spill response and cleanup-related exposures, there are no studies available for direct comparison. Our results are, however, consistent with previous non-occupational studies, including those among adults ≥ 60 years of age and among children 6-18 years of age, which found that higher blood levels of benzene metabolites were associated with greater insulin resistance (3,4). There may be sex-specific responses to benzene exposure; Choi et al. (4) showed suggestive differences in benzene metabolite-insulin resistance dose-response in humans and DeBarba et al. (5) found that among mice exposed to chronic low levels of gaseous benzene, only male mice exhibited impaired glucose tolerance and increased blood insulin levels. Though this is an important aspect of glycemic responses to volatile organic compounds, our study had too few women to adequately investigate this further.

Our main analysis results also corroborate in vitro and rodent studies that show metabolic dysfunction with exposure to benzene (5,6,41,42) and toluene (7). The inhalable exposures in the present study, including benzene, are several orders of magnitude lower (low ppb vs 50 ppm) than the inhaled exposures used in a mouse study that showed oxidative stress and metabolic dysfunction related to benzene exposure in a dose-dependent fashion (6). Our results suggest that much lower benzene exposures may follow similar patterns, though we lacked the necessary chemical-specific data to characterize the respective contributions of each agent to higher observed risks. The rodent studies referenced above did not assess delayed or persistent changes, whereas this study had several years between exposure and the outcome assessment, allowing for changes that were either delayed or undiagnosed, immediate, and persistent (6,41,42). We are unaware of any human studies examining the relationships of toluene, ethylbenzene, xylenes, or n-hexane exposures with glycemic dysregulation, but limited rodent studies of ethylbenzene and xylene have found no structural changes to the pancreas nor changes in urinary glucose levels (43,44).

We observed a significant exposure-response relationship only among overweight participants. It is possible that the higher baseline risk of developing DM among obese individuals (44) may have obscured a trend of increasing risk associated with increasing THC exposure level; there was still an apparent small increase in risk for obese workers with any THC exposure level above the reference level. We observed expected associations between BMI and DM incidence, with 71.3% of diabetics classified as obese versus 40.8% of non-diabetics. The attenuation of RRs when those with pre-diabetes were included as cases suggests that 1) oil spill cleanup-related THC exposure, if causally related to DM, may act in the later stages of disease progression or primarily among susceptible individuals and 2) any potential overreporting of diabetes diagnoses by pre-diabetics was insufficient to obscure an association. It is also possible those with prediabetes could have been pre-diabetic prior to the spill but were not excluded as prevalent cases. At the same time, attenuation of the risk estimates when using a stricter definition of DM (i.e., HbA1c ≥ 6.5% or (DM diagnosis and use of antidiabetic medication)) could be due to one or more of the following: a) some physician-diagnosed diabetic participants were managing their diabetes without antidiabetic medication, b) some participants misreported being diagnosed with DM, and/or c) some pre-diabetic participants were taking antidiabetic medication. It is unlikely that any overreporting of DM was differential by exposure status as exposure was estimated by study investigators based on participants’ detailed spill-related work histories. We lacked the data necessary to evaluate this issue further, although our data indicate that a small proportion (up to 12%) of cases may have incorrectly reported a DM diagnosis, as they had neither antidiabetic medication nor a HbA1c value ≥ 6.5%.

Strengths of this analysis of oil spill workers include its use of THC exposure estimates, based on measurements, as opposed to using job title as a proxy for exposure, the ability to identify undiagnosed DM cases via measured HbA1c, a relatively large sample size, and the ability to control for important demographic, lifestyle, and anthropometric factors, including measured BMI. In addition, it examined incident/newly identified diabetes cases rather than diabetes mortality, allowing us to account for well-managed diabetes among the still living and avoiding the documented under-ascertainment, possibly differential, resulting from use of cause of death data from vital records (45-48). It is also the first study of the association between oil spill response and cleanup-related exposures and risk of DM.

Limitations of this study include possible outcome misclassification because case ascertainment relied partially on self-reported physician diagnosis of DM; however, self-reported DM has positive predictive values of 72%-94.9% in long term cohort studies with multiple follow-up phases (49-51), and we were able to detect unreported/undiagnosed DM cases with measured HbA1c levels. Because we had HbA1c level measured only at the clinical exam, we were unable to exclude any individuals with prevalent, but undiagnosed, DM prior to the start of follow-up; this is expected to bias our estimates toward the null. Additionally, because covariate data were missing for less than 2% of study participants, our complete case analysis is unlikely to have substantially affected results. The follow-up period was not the same for every individual, as the phases of the study were completed over multiple years, though this difference in follow-up time is unlikely to bias this analysis because it is unlikely to be associated with exposure and because DM may develop or progress to diagnosis very slowly. Additionally, the maximum THC exposure metric does not take into account how frequently this maximum occurred, nor does it account for cumulative exposure over time.

These results suggest an association between oil spill response and cleanup-related THC exposure and increased risk of DM. Future studies on this topic would benefit from incorporating information about individual agents within oil spill cleanup-related THC, allowing analysis of the joint effects of individual agents.

Supplementary Material

1

Highlights:

  • Prior studies have not examined the relationship between risk of type 2 diabetes and oil spill cleanup-related exposures.

  • This study used data from the Gulf Long Term Follow-up Study, which is a prospective cohort of individuals who completed training required to work on the Deepwater Horizon spill cleanup and response.

  • This study found a trend of increasing risk of diabetes with increasing total hydrocarbons exposure level among workers up to 6 years after exposure, with a significant trend among overweight workers.

  • Our findings are consistent with related literature concerning exposure to components of crude oil and glycemic dysregulation.

Acknowledgement

The authors would like to thank Braxton Jackson and Mark Bodkin for data management and analytic support on this project.

Funding sources

This work was supported by the National Institutes of Health (NIH) Common Fund and the Intramural Research Program of the NIH, and the National Institute of Environmental Health Sciences [ZO1 ES 102945] and National Institute of Occupational Safety and Health (NIOSH) training grant [5T42OH008673].

Footnotes

Ethics approval

The Gulf Long Term Follow-up Study was approved by the Institutional Review Board at the US National Institute of Environmental Health Sciences.

Conflict of interest statement

No other authors report any conflicts of interest.

Declaration of interests

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Data availability

Data from the GuLF Study, including data used in this analysis, may be requested following procedures described at https://gulfstudy.nih.gov/en/forresearchers.html.

References

  • 1.U.S. Coast Guard. On scene coordinator report Deepwater Horizon oil spill: submitted to the National Response Team, September 2010. Washington D.C.: U.S. Department of Homeland Security; 2011. p. 222. [Google Scholar]
  • 2.Reddy CM, Arey JS, Seewald JS, Sylva SP, Lemkau KL, Nelson RK, et al. Composition and fate of gas and oil released to the water column during the Deepwater Horizon oil spill. Proc Natl Acad Sci. 2012. Dec 11;109(50):20229–34. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Amin MM, Rafiei N, Poursafa P, Ebrahimpour K, Mozafarian N, Shoshtari-Yeganeh B, et al. Association of benzene exposure with insulin resistance, SOD, and MDA as markers of oxidative stress in children and adolescents. Environ Sci Pollut Res. 2018. Dec;25(34):34046–52. [DOI] [PubMed] [Google Scholar]
  • 4.Choi Y-H, Kim JH, Lee B-E, Hong Y-C. Urinary benzene metabolite and insulin resistance in elderly adults. Sci Total Environ. 2014. Jun;482–483:260–8. [DOI] [PubMed] [Google Scholar]
  • 5.Debarba LK, Mulka A, Lima JBM, Didyuk O, Fakhoury P, Koshko L, et al. Acarbose protects from central and peripheral metabolic imbalance induced by benzene exposure. Brain Behav Immun. 2020. Jun;S0889159120303457. [DOI] [PubMed] [Google Scholar]
  • 6.Abplanalp WT, Wickramasinghe NS, Sithu SD, Conklin DJ, Xie Z, Bhatnagar A, et al. Benzene exposure induces insulin resistance in mice. Toxicol Sci. 2019. Feb 1;167(2):426–37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Dick ALW, Simpson A, Qama A, Andrews Z, Lawrence AJ, Duncan JR. Chronic intermittent toluene inhalation in adolescent rats results in metabolic dysfunction with altered glucose homeostasis: Inhalant abuse induces metabolic dysfunction. Br J Pharmacol. 2015. Nov;172(21):5174–87. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Buthbumrung N, Mahidol C, Navasumrit P, Promvijit J, Hunsonti P, Autrup H, et al. Oxidative DNA damage and influence of genetic polymorphisms among urban and rural schoolchildren exposed to benzene. Chem Biol Interact. 2008. Apr;172(3):185–94. [DOI] [PubMed] [Google Scholar]
  • 9.Costa-Amaral IC, Carvalho LVB, Santos MVC, Valente D, Pereira AC, Figueiredo VO, et al. Environmental assessment and evaluation of oxidative stress and genotoxicity biomarkers related to chronic occupational exposure to benzene. Int J Environ Res Public Health [Internet], 2019. Jun [cited 2020 Apr 11];16(12). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617122/ [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Kim JH, Moon JY, Park E-Y, Lee K-H, Hong Y-C. Changes in oxidative stress biomarker and gene expression levels in workers exposed to volatile organic compounds. Ind Health. 2011;49(1):8–14. [DOI] [PubMed] [Google Scholar]
  • 11.Lagorio S, Tagesson C, Forastiere F, lavarone I, Axelson O, Carere A. Exposure to benzene and urinary concentrations of 8-hydroxydeoxyguanosine, a biological marker of oxidative damage to DNA. Occup Environ Med. 1994. Nov;51(11):739–43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Liu YZ, Roy-Engel AM, Baddoo MC, Flemington EK, Wang G, Wang H. The impact of oil spill to lung health-insights from an RNA-seq study of human airway epithelial cells. Gene. 2016;578(1):38–51. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Midorikawa K, Uchida T, Okamoto Y, Toda C, Sakai Y, Ueda K, et al. Metabolic activation of carcinogenic ethylbenzene leads to oxidative DNA damage. Chem Biol Interact. 2004. Dec 7;150(3):271–81. [DOI] [PubMed] [Google Scholar]
  • 14.Moro AM, Brucker N, Charão M, Bulcão R, Freitas F, Baierle M, et al. Evaluation of genotoxicity and oxidative damage in painters exposed to low levels of toluene. Mutat Res Toxicol Environ Mutagen. 2012. Jul;746(1):42–8. [DOI] [PubMed] [Google Scholar]
  • 15.Salimi A, Talatappe BS, Pourahmad J. Xylene induces oxidative stress and mitochondria damage in isolated human lymphocytes. Toxicol Res. 2017. Jul;33(3):233–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Uzma N, Kumar BS, Hazari MAH. Exposure to benzene induces oxidative stress, alters the immune response and expression of p53 in gasoline filling workers. Am J Ind Med. 2010. Dec;53(12):1264–70. [DOI] [PubMed] [Google Scholar]
  • 17.Vestergaard S, Loft S, Møller P. Role of inducible nitrogen oxide synthase in benzene-induced oxidative DNA damage in the bone marrow of mice. Free Radic Biol Med. 2002. Mar 1;32(5):481–4. [DOI] [PubMed] [Google Scholar]
  • 18.Zhang M, Wang Y, Wang X, Liu J, Zhang J, Gu Q. Roles of oxidative stress, apoptosis, and heme oxygenase-1 in ethylbenzene-induced renal toxicity in NRK-52E cells. Toxicol Ind Health. 2016. Dec 1;32(12):1952–60. [DOI] [PubMed] [Google Scholar]
  • 19.Dokken BB, Saengsirisuwan V, Kim JS, Teachey MK, Henriksen EJ. Oxidative stress-induced insulin resistance in rat skeletal muscle: role of glycogen synthase kinase-3. Am J Physiol-Endocrinol Metab. 2008. Mar;294(3):E615–21. [DOI] [PubMed] [Google Scholar]
  • 20.Gardner CD, Eguchi S, Reynolds CM, Eguchi K, Frank GD, Motley ED. Hydrogen peroxide inhibits insulin signaling in vascular smooth muscle cells. Exp Biol Med. 2003. Jul;228(7):836–42. [DOI] [PubMed] [Google Scholar]
  • 21.Modak MA, Parab PB, Ghaskadbi SS. Pancreatic islets are very poor in rectifying oxidative DNA damage. Pancreas. 2009. Jan;38(1):23–9. [DOI] [PubMed] [Google Scholar]
  • 22.Pi J, Bai Y, Zhang Q, Wong V, Floering LM, Daniel K, et al. Reactive oxygen species as a signal in glucose-stimulated insulin secretion. Diabetes. 2007. Jul 1;56(7):1783–91. [DOI] [PubMed] [Google Scholar]
  • 23.Pi J, Zhang Q, Fu J, Woods C, Hou Y, Corkey BE, et al. ROS signaling, oxidative stress and Nrf2 in pancreatic beta-cell function. Toxicol Appl Pharmacol. 2010. Apr;244(1):77–83. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Cavaliere G, Viggiano E, Trinchese G, De Filippo C, Messina A, Monda V, et al. Long feeding high-fat diet induces hypothalamic oxidative stress and inflammation, and prolonged hypothalamic AMPK activation in rat animal model. Front Physiol [Internet], 2018. Jul 6 [cited 2020 Jul 9];9. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6043859/ [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Gerber PA, Rutter GA. The role of oxidative stress and hypoxia in pancreatic beta-cell dysfunction in diabetes mellitus. Antioxid Redox Signal. 2017;26(10):501–18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Kjaergaard M, Nilsson C, Nielsen MO, Grove K, Raun K. Hypothalamic oxidative stress and inflammation, and peripheral glucose homeostasis in Sprague-Dawley rat offspring exposed to maternal and postnatal chocolate and soft drink. Nutr Diabetes [Internet]. 2018. Jul 19 [cited 2020 Jul 9];8. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053394/ [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Kovačević S, Nestorov J, Matić G, Elaković I. Chronic stress combined with a fructose diet reduces hypothalamic insulin signaling and antioxidative defense in female rats. Neuroendocrinology. 2019;108(4):278–90. [DOI] [PubMed] [Google Scholar]
  • 28.Singh MP, Reddy MMKrishna, Mathur N, Saxena DK, Chowdhuri DK. Induction of hsp70, hsp60, hsp83 and hsp26 and oxidative stress markers in benzene, toluene and xylene exposed Drosophila melanogaster: Role of ROS generation. Toxicol Appl Pharmacol. 2009. Mar;235(2):226–43. [DOI] [PubMed] [Google Scholar]
  • 29.Singh MP, Ravi Ram K, Mishra M, Shrivastava M, Saxena DK, Chowdhuri DK. Effects of co-exposure of benzene, toluene and xylene to Drosophila melanogaster: Alteration in hsp70, hsp60, hsp83, hsp26, ROS generation and oxidative stress markers. Chemosphere. 2010. Apr;79(5):577–87. [DOI] [PubMed] [Google Scholar]
  • 30.Kwok RK, Engel LS, Miller AK, Blair A, Curry MD, Jackson WB, et al. The GuLF STUDY: A prospective study of persons involved in the Deepwater Horizon oil spill response and clean-up. Environ Health Perspect. 2017. Apr;125(4):570–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.McMichael AJ. Standardized mortality ratios and the “Healthy Worker Effect”: Scratching beneath the surface. J Occup Med. 1976;18(3):165–168. [DOI] [PubMed] [Google Scholar]
  • 32.American Diabetes Association. 8. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2018. Diabetes Care. 2018;41(Supplement 1):S73–S85. doi: 10.2337/dc18-S008 [DOI] [PubMed] [Google Scholar]
  • 33.Stewart PA, Stenzel MR, Ramachandran G, Banerjee S, Huynh TB, Groth CP, et al. Development of a total hydrocarbon ordinal job-exposure matrix for workers responding to the Deepwater Horizon disaster: The GuLF STUDY. J Expo Sci Environ Epidemiol. 2018. May;28(3):223–30. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.American Diabetes Association. Classification and diagnosis of diabetes: Standards of medical care in diabetes-2018. Diabetes Care. 2018. Jan;41(Supplement 1):S13–27.29222373 [Google Scholar]
  • 35.Greenland S, Pearl J, Robins JM. Causal diagrams for epidemiologic research. Epidemiology. 1999;10(1):37–48. [PubMed] [Google Scholar]
  • 36.Centers for Disease Control. Defining Adult Overweight and Obesity [Internet]. 2019. [cited 2019 Oct 15]. Available from: https://www.cdc.gov/obesity/adult/defining.html
  • 37.Morley LC, Tang T, Yasmin E, Norman RJ, Balen AH. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev [Internet]. 2017. [cited 2020 Sep 14];(11). Available from: https://www.readcube.com/articles/10.1002%2F14651858.CD003053.pub6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Okoroh EM, Hooper WC, Atrash HK, Yusuf HR, Boulet SL. Prevalence of polycystic ovary syndrome among the privately insured, United States, 2003-2008. Am J Obstet Gynecol. 2012. Oct 1;207(4):299.e1–299.e7. [DOI] [PubMed] [Google Scholar]
  • 39.Deddens JA, Petersen MR. Approaches for estimating prevalence ratios. Occupational and Environmental Medicine. 2008;65(7):501–506. doi: 10.1136/oem.2007.034777 [DOI] [PubMed] [Google Scholar]
  • 40.Petersen MR, Deddens JA. A revised SAS macro for maximum likelihood estimation of prevalence ratios using the COPY method. Occupational and Environmental Medicine. 2009;66(9):639–639. doi: 10.1136/oem.2008.043018 [DOI] [PubMed] [Google Scholar]
  • 41.Bahadar H, Maqbool F, Mostafalou S, Baeeri M, Gholami M, Ghafour-Boroujerdi E, et al. The molecular mechanisms of liver and islets of Langerhans toxicity by benzene and its metabolite hydroquinone in vivo and in vitro. Toxicol Mech Methods. 2015. Oct 13;25(8):628–36. [DOI] [PubMed] [Google Scholar]
  • 42.Bahadar H, Maqbool F, Mostafalou S, Baeeri M, Rahimifard M, Navaei-Nigjeh M, et al. Assessment of benzene induced oxidative impairment in rat isolated pancreatic islets and effect on insulin secretion. Environ Toxicol Pharmacol. 2015. May;39(3):1161–9. [DOI] [PubMed] [Google Scholar]
  • 43.Kükner A, Canpolat L, Ozan E, Gökçimen A, Ozan S, Doğrul M. The effect of xylene inhalation on the rat liver. Acta Physiol Hung. 1997 1998;85(3):231–41. [PubMed] [Google Scholar]
  • 44.Mellert W, Deckardt K, Kaufmann W, van Ravenzwaay B. Ethylbenzene: 4- and 13-week rat oral toxicity. Arch Toxicol Arch Für Toxikol Heidelb. 2007. May;81(5):361–70. [DOI] [PubMed] [Google Scholar]
  • 45.Centers for Disease Control. National Diabetes Statistics Report, 2017. 2017. p. 20. [Google Scholar]
  • 46.Cheng WS, Wingard DL, Kritz-Silverstein D, Barrett-Connor E. Sensitivity and Specificity of Death Certificates for Diabetes: As good as it gets? Diabetes Care. 2008. Feb 1;31(2):279–84. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.McEwen LN, Kim C, Haan M, Ghosh D, Lantz PM, Mangione CM, et al. Diabetes Reporting as a Cause of Death: Results from the Translating Research Into Action for Diabetes (TRIAD) study. Diabetes Care. 2006. Feb 1;29(2):247–53. [DOI] [PubMed] [Google Scholar]
  • 48.Saydah SH, Geiss LS, Tierney E, Benjamin SM, Engelgau M, Brancati F. Review of the performance of methods to identify diabetes cases among vital statistics, administrative, and survey data. Ann Epidemiol. 2004. Aug;14(7):507–16. [DOI] [PubMed] [Google Scholar]
  • 49.Goldman N, Lin I, Weinstein M, Lin Y. Evaluating the quality of self-reports of hypertension and diabetes. J Clin Epidemiol. 2003;56(2):148–54. [DOI] [PubMed] [Google Scholar]
  • 50.Margolis KL, Qi L, Brzyski R, Bonds DE, Howard BV, Kempainen S, et al. Validity of diabetes self-reports in the Women’s Health Initiative: comparison with medication inventories and fasting glucose measurements. Clin Trials Lond Engl. 2008;5(3):240–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Pastorino S, Richards M, Hardy R, Abington J, Wills A, Kuh D, et al. Validation of self-reported diagnosis of diabetes in the 1946 British birth cohort. Prim Care Diabetes. 2015. Oct;9(5):397–400. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

1

Data Availability Statement

Data from the GuLF Study, including data used in this analysis, may be requested following procedures described at https://gulfstudy.nih.gov/en/forresearchers.html.

RESOURCES